Development and Implementation of Health and Wellness CBT for Individuals with Depression and HIV
- PMID: 24795524
- PMCID: PMC4002170
- DOI: 10.1016/j.cbpra.2013.07.003
Development and Implementation of Health and Wellness CBT for Individuals with Depression and HIV
Abstract
Rates of depression are reported to be between 22-33% in adults with HIV, which is double that of the general population. Depression negatively affects treatment adherence and health outcomes of those with medical illnesses. Further, it has been shown in adults that reducing depression may improve both adherence and health outcomes. To address the issues of depression and non-adherence, Health and Wellness (H&W) Cognitive Behavioral Therapy (CBT) and medication management (MM) treatment strategies have been developed specifically for youth living with both HIV and depression. H&W CBT is based on other studies with uninfected youth and upon research on adults with HIV. H&W CBT uses problem-solving, motivational interviewing, and cognitive-behavioral strategies to decrease adherence obstacles and increase wellness. The intervention is delivered in 14 planned sessions over a 6-month period, with three different stages of CBT. This paper summarizes the feasibility and acceptability data from an open depression trial with 8 participants, 16-24 years of age, diagnosed with HIV and with a Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) diagnosis of depression, conducted at two treatment sites in the Adolescent Trials Network (ATN). Both therapists and subjects completed a Session Evaluation Form (SEF) after each session, and results were strongly favorable. Results from The Quick Inventory of Depressive Symptomatology-Clinician (QIDS-C) also showed noteworthy improvement in depression severity. A clinical case vignette illustrates treatment response. Further research will examine the use of H&W CBT in a larger trial of youth diagnosed with both HIV and depression.
Keywords: Adherence; Cognitive Behavioral Therapy (CBT); Health; Human Immunodeficiency Virus (HIV); Major Depressive Disorder (MDD).
Figures
Similar articles
-
Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV.Cognit Ther Res. 2024 Aug;48(4):781-790. doi: 10.1007/s10608-024-10474-0. Epub 2024 Mar 28. Cognit Ther Res. 2024. PMID: 39664885 Free PMC article.
-
Implementation of a Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression of People Living with HIV in Korea.Infect Chemother. 2022 Dec;54(4):733-743. doi: 10.3947/ic.2022.0118. Epub 2022 Nov 11. Infect Chemother. 2022. PMID: 36450289 Free PMC article.
-
Description and Demonstration of Cognitive Behavioral Therapy to Enhance Antiretroviral Therapy Adherence and Treat Depression in HIV-Infected Adults.Cogn Behav Pract. 2015 Nov 1;22(4):430-438. doi: 10.1016/j.cbpra.2014.02.001. Cogn Behav Pract. 2015. PMID: 26688659 Free PMC article.
-
[A group cognitive behavioral intervention for people registered in supported employment programs: CBT-SE].Encephale. 2014 Jun;40 Suppl 2:S81-90. doi: 10.1016/j.encep.2014.04.005. Epub 2014 Jun 16. Encephale. 2014. PMID: 24948482 Review. French.
-
Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.Health Technol Assess. 2005 Nov;9(42):1-174. doi: 10.3310/hta9420. Health Technol Assess. 2005. PMID: 16266559 Review.
Cited by
-
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States.J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):497-505. doi: 10.1097/QAI.0000000000002790. J Acquir Immune Defic Syndr. 2021. PMID: 34483297 Free PMC article. Clinical Trial.
-
Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):38-46. doi: 10.1097/QAI.0000000000000803. J Acquir Immune Defic Syndr. 2016. PMID: 26761270 Free PMC article. Clinical Trial.
-
Interventions to address the mental health of adolescents and young adults living with or affected by HIV: state of the evidence.J Int AIDS Soc. 2021 Jun;24 Suppl 2(Suppl 2):e25713. doi: 10.1002/jia2.25713. J Int AIDS Soc. 2021. PMID: 34164939 Free PMC article. Review.
-
Understanding HIV-Related Pill Aversion as a Distinct Barrier to Medication Adherence.Behav Med. 2019 Oct-Dec;45(4):294-303. doi: 10.1080/08964289.2018.1534076. Epub 2019 Jan 3. Behav Med. 2019. PMID: 30605010 Free PMC article.
-
HIV-Associated Neurocognitive Disorder (HAND): Relative Risk Factors.Curr Top Behav Neurosci. 2021;50:401-426. doi: 10.1007/7854_2020_131. Curr Top Behav Neurosci. 2021. PMID: 32720161
References
-
- Bing BE, Burman MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry. 2001;58(8):721–728. - PubMed
-
- Birmaher B, Brent DA, Issues TWGoQ, Staff A. Practice Parameter for the Assessment and Treatment of Children and Adolescents with Depressive Disorder. [practice parameters] Journal of the American Academy of Child & Adolescent Psychiatry. 2007;46(11):24. - PubMed
-
- Brunstein-Klomek A, Zalsman G, Mufson L. Interpersonal psychotherapy for depressed adolescents (IPT-A) Israel Journal of Psychiatry & Related Sciences. 2007;44(1):40–46. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases